Researchers at Hanyang University in South Korea have developed an artificial intelligence-guided, four-dimensional-printed microneedle patch capable of autonomously adapting to biological environments to accelerate diabetic wound healing. Published in Advanced Materials, the study introduces a biomimetic platform that combines machine learning, programmable biomaterials, and targeted therapeutics to address chronic non-healing ulcers. The innovation draws structural inspiration from Drosera capensis, a carnivorous plant that traps prey through coordinated mechanical movement and adhesion. Translating this natural behavior into a biomedical device, the research team engineered shape-memory microneedles that automatically bend at physiological temperature to draw wound edges together. Unlike conventional sutures or adhesives, which passively hold tissue, the patch actively responds to the body thermal environment to maintain stable contact and promote closure. Artificial intelligence played a critical role in optimizing the manufacturing process. The researchers deployed Gaussian Process Regression models to predict how varying material compositions and fabrication parameters would influence shape-recovery kinetics. This machine-learning approach significantly reduced trial-and-error experimentation, identifying an optimal production window that balanced mechanical durability with rapid thermal actuation. By translating biological principles into programmable engineering specifications, artificial intelligence enabled precise control over the patch dynamic behavior. Beyond mechanical wound closure, the microneedle system delivers a dual-action therapeutic payload. The platform integrates adhesive deoxyribonucleic acid nanoparticles designed to stimulate endothelial and fibroblast proliferation, thereby accelerating tissue regeneration. Concurrently, a zinc-functionalized surface provides sustained antibacterial defense against common pathogens such as Escherichia coli and Staphylococcus aureus. In preclinical trials, the integrated device demonstrated superior wound contraction, reduced infection risk, and enhanced histological repair compared to standard therapeutic controls. The development marks a convergence of artificial intelligence, additive manufacturing, and regenerative medicine. While clinical translation requires further validation, the underlying AI-driven four-dimensional-printing framework holds broader applications in adaptive biomedical engineering. Potential extensions include soft robotics, implantable scaffolds, and vascular stents that require programmable motion and reliable tissue interfacing. By merging nature-inspired design with computational optimization, the Hanyang University team has established a scalable pathway toward responsive smart biomaterials capable of mitigating healing complications in chronic diabetic care.